Identification of a EML4-ALK exon 19 fusion variant in lung adenocarcinoma and alectinib resistance. Liu D, Xu X, Wen J, Zhang C, et al. Lung Cancer 2021;160:32-35.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu D, Xu X, Wen J, Zhang C, et al. Identification of a EML4-ALK exon 19 fusion variant in lung adenocarcinoma and alectinib resistance. Lung Cancer 2021;160:32-35.
PMID: 34391065